Immunohistochemical Study of the Expression of Drug-resistant Proteins in Large Cell Neuroendocrine Carcinoma of the Lung

Japanese Journal of Thoracic and Cardiovascular Surgery

Volumn 51, Issue 7, 2003, Pages 272-276

  Okada, Daisuke ^a   Kawamoto, Masashi ^a   Koizumi, Kiyoshi ^a   Tanaka, Shigeo ^a   Fukuda, Yuh ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Glutathione S transferase ; Large cell neuroendocrine carcinoma; Metallothionein; Multimodality therapy; P glycoprotein

Indexed keywords

CISPLATIN; ETOPOSIDE; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE P1; GLYCOPROTEIN P; METALLOTHIONEIN; TEGAFUR; UFT; UNCLASSIFIED DRUG; URACIL DERIVATIVE; ANTINEOPLASTIC AGENT; GSTP1 PROTEIN, HUMAN; ISOENZYME;

ADULT; AGED; CANCER ADJUVANT THERAPY; CANCER SURGERY; CELL TYPE; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARGE CELL CARCINOMA; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG LARGE CELL NEUROENDOCRINE CARCINOMA; LUNG SQUAMOUS CELL CARCINOMA; MALE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; WORLD HEALTH ORGANIZATION; ADJUVANT THERAPY; ARTICLE; BIOSYNTHESIS; CANCER STAGING; CARCINOMA; COMPARATIVE STUDY; EVALUATION; FOLLOW UP; JAPAN; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MIDDLE AGED; MORTALITY; PATHOLOGY; SURGERY;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, LARGE CELL; CARCINOMA, NEUROENDOCRINE; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; FOLLOW-UP STUDIES; GLUTATHIONE S-TRANSFERASE PI; GLUTATHIONE TRANSFERASE; HUMANS; IMMUNOHISTOCHEMISTRY; ISOENZYMES; JAPAN; LUNG NEOPLASMS; MALE; METALLOTHIONEIN; MIDDLE AGED; NEOPLASM STAGING; P-GLYCOPROTEIN; RADIOTHERAPY, ADJUVANT; SURGICAL PROCEDURES, OPERATIVE;

EID: 0042733343     PISSN: 13444964     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02719377     Document Type: Conference Paper

References (15)

1. Travis WD, Colby TV, Corrin B, Shimosato Y, Brambilla E. Histological typing of lung and pleural tumors, 3rd edition. "In World Health Organization: International histological classification of tumours" 1999; Springer-Verlag, Berlin, Germany.
2. Jiang SX, Kameya T, Shoji M, Dobashi Y, Shinada J, Yoshimura H. Large cell neuroendocrine carcinoma of the lung: A histologic and immunohistochemical study of 22 cases. Am J Surg Pathol 1998; 22: 526-37.
3. Travis WD, Rush W, Flieder DB, Falk R, Fleming MV, Gal AA, et al. Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid and its separation from typical carcinoid. Am J Surg Pathol 1998; 22: 934-44.
4. García-Yuste M, Matilla JM, Alvarez-Gago T, Duque JL, Heras F, Cerezal LJ, et al. Prognostic factors in neuroendocrine lung tumors: A Spanish multicenter study. Ann Thorac Surg 2000; 70: 258-63.
5. Dresler CM, Ritter JH, Patterson GA, Rose E, Bailey MS, Wick MR. Clinical-pathologic analysis of 40 patients with large cell neuroendocrine carcinoma of the lung. Ann Thorac Surg 1997; 63: 180-5.
6. Yamanishi M, Takeuchi S, Kurashima R, Kawamoto M, Koizumi K, Shibuya M, et al. High survival rate of 6 cases of pulmonary large cell neuroendocrine carcinoma formerly classified as small cell carcinoma. J Nippon Med Sch 2001; 68: 335-9.
7. Carretta A, Ceresoli GL, Arrigoni G, Canneto B, Reni M, Cigala C, et al. Diagnostic and therapeutic management of neuroendocrine lung tumors. A clinical study of 44 cases. Lung Cancer 2000; 29: 217-25.
8. Iyoda A, Hiroshima K, Toyozaki T, Haga Y, Baba M, Fujisawa T, et al. Adjuvant chemotherapy for large cell carcinoma with neuroendocrine features. Cancer 2001; 92: 1108-12.
9. Cooper WA, Thourani VH, Gal AA, Lee RB, Mansour KA, Miller JI. The surgical spectrum of pulmonary neuroendocrine neoplasms. Chest 2001; 119: 14-8.
10. Kawasaki M, Nakanishi Y, Kuwano K, Takayama K, Kiyohara C, Hara N. Immunohistohemically detected p53 and P-glycoprotein predict the response to chemotherapy in lung cancer. Eur Four Cancer 1998; 34: 1352-7.
11. Yokoyama H, Ishida T, Sugio K, Inoue T, Sugimachi K. Immunohistochemical evidence that P-glycoprotein in non-small cell lung cancers is associated with shorter survival. Surg Today 1999; 29: 1141-7.
12. Fujino S, Sakamoto A, Fukuda M, Takatani H, Fukuda M, Soda H, et al. Expression of glutathione S-transferase-π and metallothionein in lung cancer Eng abstr). Haigan 1997; 37: 135-41.
13. Bai F, Nakanishi Y, Kawasaki M, Takayama K, Yasunami J, Pei XH, et al. Immunohistochemical expression of glutathione S-transferase-π can predict chemotherapy response in patients with non-small cell lung carcinoma. Cancer 1996; 78: 416-21.
14. Kurane S, Kobayashi K, Nukariya N, Morikawa T, Hino M, Sibuya M, et al. Pilot study of multi-cyclic combination chemotherapy for small cell lung cancer patient. Jpn J Cancer Chemother 1991; 18: 489-92.
15. Tojo S, Tada H, Inoue K, Yamamoto R, Kishi A, Asada H, et al. Three cases of large cell neuroendocrine carcinoma diagnosed as small cell carcinoma, treated with adjuvant chemotherapy before surgery (Jpn abstr). Haigan 2000; 40: 563.